Literature DB >> 30912032

Development and Feasibility of SymTrak, aMulti-domain Tool for Monitoring Symptoms of Older Adults in Primary Care.

Patrick O Monahan1,2, Kurt Kroenke3,4,5, Christopher M Callahan3,5,6, Tamilyn Bakas7, Amanda Harrawood6, Phillip Lofton6, Danielle Frye6, Claire Draucker7, Timothy Stump3, Debra Saliba8, James E Galvin9, Amanda Keegan6, Mary G Austrom10, Malaz Boustani3,5,6.   

Abstract

BACKGROUND: A clinically practical, brief, user-friendly, multi-domain self-report and caregiver-report tool is needed for tracking actionable symptoms in primary care for elderly patients with multiple chronic conditions (MCCs).
OBJECTIVE: Develop and assess usability, administration time, and internal reliability of SymTrak. DESIGN AND PARTICIPANTS: Phase I: legacy instruments, content validity, analyses of existing data, focus groups (physicians, nurses, patients, informal caregivers), and Think Aloud interviews (patients, caregivers) were used to develop SymTrak. Phase II (pilot feasibility study): 81 (27 patient-caregiver dyads, 27 patients without an identified caregiver) participants were self-administered SymTrak in clinic. MAIN MEASURES: SymTrak and demographic questions. KEY
RESULTS: Consistent themes emerged from phase I focus groups. Ambiguous wording was corrected with Think Aloud feedback. In phase II, patients and caregivers preferred circling words instead of numbers for item response options. SymTrak self-administration completion time in clinic was brief; mean was 2.4, 3.0, and 3.3 min for the finalized circlingwords version, respectively, for caregivers, dyadic patients, and patients without a caregiver; and the maximum was 6.2 min for any participant. Usability questionnaire ratings were high. Cronbach's alpha for the SymTrak 23-item total score was 0.86, 0.79, and 0.81 for caregivers, dyadic patients, and patients without a caregiver, respectively.
CONCLUSIONS: SymTrak demonstrates content validity, positive qualitative findings, high perceived usability, brief self-administered completion time, and good internal reliability.

Entities:  

Keywords:  aging; chronic disease; primary care; psychometrics; self-management; symptoms

Year:  2019        PMID: 30912032      PMCID: PMC6544681          DOI: 10.1007/s11606-018-4772-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  38 in total

Review 1.  Communication between older patients and their physicians.

Authors:  R D Adelman; M G Greene; M G Ory
Journal:  Clin Geriatr Med       Date:  2000-02       Impact factor: 3.076

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams
Journal:  Psychosom Med       Date:  2002 Mar-Apr       Impact factor: 4.312

4.  Health, cognitive, and psychosocial factors as predictors of mortality in an elderly community sample.

Authors:  A E Korten; A F Jorm; Z Jiao; L Letenneur; P A Jacomb; A S Henderson; H Christensen; B Rodgers
Journal:  J Epidemiol Community Health       Date:  1999-02       Impact factor: 3.710

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

6.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

Review 7.  Studying symptoms: sampling and measurement issues.

Authors:  K Kroenke
Journal:  Ann Intern Med       Date:  2001-05-01       Impact factor: 25.391

Review 8.  Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management.

Authors:  Kurt Kroenke
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

9.  Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses.

Authors:  Bernd Löwe; Robert L Spitzer; Kerstin Gräfe; Kurt Kroenke; Andrea Quenter; Stephan Zipfel; Christine Buchholz; Steffen Witte; Wolfgang Herzog
Journal:  J Affect Disord       Date:  2004-02       Impact factor: 4.839

10.  The Health Utilities Index (HUI): concepts, measurement properties and applications.

Authors:  John Horsman; William Furlong; David Feeny; George Torrance
Journal:  Health Qual Life Outcomes       Date:  2003-10-16       Impact factor: 3.186

View more
  5 in total

1.  Capsule Commentary on Monahan et al., Development and Feasibility of SymTrak, a Multi-Domain Tool for Monitoring Symptoms of Older Adults in Primary Care.

Authors:  Jeffrey L Jackson
Journal:  J Gen Intern Med       Date:  2019-06       Impact factor: 5.128

2.  Reliability and Validity of SymTrak, a Multi-Domain Tool for Monitoring Symptoms of Older Adults with Multiple Chronic Conditions.

Authors:  Patrick O Monahan; Kurt Kroenke; Christopher M Callahan; Tamilyn Bakas; Amanda Harrawood; Phillip Lofton; Danielle Frye; Claire Draucker; Timothy Stump; Debra Saliba; James E Galvin; Amanda Keegan; Mary G Austrom; Malaz Boustani
Journal:  J Gen Intern Med       Date:  2019-04-18       Impact factor: 5.128

3.  Agreement between older adult patient and caregiver proxy symptom reports.

Authors:  Kurt Kroenke; Timothy E Stump; Patrick O Monahan
Journal:  J Patient Rep Outcomes       Date:  2022-05-14

4.  SymTrak-8 as a Brief Measure for Assessing Symptoms in Older Adults.

Authors:  Patrick O Monahan; Kurt Kroenke; Timothy E Stump
Journal:  J Gen Intern Med       Date:  2020-11-10       Impact factor: 5.128

5.  Feasibility of a minimal dataset for adults with acquired brain injury in Dutch healthcare practice.

Authors:  Anne-Fleur Domensino; Jolanda C M van Haastregt; Ieke Winkens; Coen A M van Bennekom; Caroline M van Heugten
Journal:  PLoS One       Date:  2020-06-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.